Market Mover: Nutrien (NTR) Climbs at Midday May 13

Equities Staff  |

Nutrien Ltd (NYSE: NTR) has risen $5.32 (5.58%) and sits at $100.44, as of 12:04:37 est on May 13.

1,103,020 shares have exchanged hands.

The Company has fallen 7.83% over the last 5 days and shares lost 12.36% over the last 30 days.

Nutrien expects its next earnings on 2022-08-03.

For technical charts, analysis, and more on Nutrien visit the company profile.

About Nutrien Ltd

Nutrien is the world's largest provider of crop inputs and services, playing a critical role in helping growers increase food production in a sustainable manner. The Company produces and distributes 27 million tonnes of potash, nitrogen and phosphate products world-wide. With this capability and its leading agriculture retail network, the Company is well positioned to supply the needs of its customers. It operates with a long-term view and is committed to working with its stakeholders as they address economic, environmental and social priorities. The scale and diversity of integrated portfolio provides a stable earnings base, multiple avenues for growth and the opportunity to return capital to shareholders.

To get more information on Nutrien Ltd and to follow the company's latest updates, you can visit the company's profile page here: Nutrien Ltd's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:

Trending Articles

Twitter Down 13% in Premarket Trading Friday as Musk Puts Deal on Hold
The Best Laid Plans of Mice and Men — Part I
Bumble Beats First Quarter Estimates, Has Over 3 Million Paying Users
Squarespace Beats Revenue Estimates With Record Q1
BridgeBio Pharma Inks Licensing Deal With Bristol Myers Squibb Worth up to $905 Million
How To Trade in a Bearish Market
AbbVie and Teva Weighing $5 Billion Opioid Lawsuit Settlement

Market Movers

Sponsored Financial Content